期刊文献+

HPLC法测定注射用阿洛西林钠舒巴坦钠中的有关物质

Related substances of azlocillin sodium and sulbactam sodium for injection by HPLC
下载PDF
导出
摘要 目的利用HPLC法测定注射用阿洛西林钠舒巴坦钠中的有关物质。方法采用Hypersil C18(250 mm×4.6 mm,5μm)为色谱柱,以水-乙腈-磷酸盐缓冲液(pH值5.8)(体积比30∶30∶100)为流动相,流速为1.0 mL·min^-1,检测波长为210 nm。结果在该色谱条件下,阿洛西林与舒巴坦分离良好,阿洛西林钠有关物质测定中阿洛西林钠的质量浓度在0.408~20.4 mg·L^-1内线性关系良好,r=0.999 0,舒巴坦钠有关物质测定中舒巴坦钠的质量浓度在1.132~22.64 mg·L^-1内线性关系良好,r=0.999 9;阿洛西林钠最低检出限为81.2μg·L-1,舒巴坦钠最低检出限为0.566 mg·L-1;阿洛西林钠最低定量限为0.406 mg·L^-1,舒巴坦钠最低定量限为1.132 mg·L^-1。结论该方法简便、灵敏、准确可靠,可有效测定注射用阿洛西林钠舒巴坦钠中的有关物质。 Objective To determine the related substances of azlocillin sodium and sulbactam sodium for in- jection by HPLC. Methods a Hypersil C18 column(250 mm ×4.6 mm,5 μm) was used in the HPLC sys- tem;water-acetonitrile-phosphate buffer solution( pH 5.8 ) (potassium dihydrogen phosphate 8.34 g and di- potassium hydrogen phosphate 0. 87 g was dissolved and diluted to 1 000 mL with water) ( V: V: V = 30: 30: 100)was selected as mobile phase;the flow rate was 1.0 mL·min^-1, the detection wavelength was set at 210 nm. Results Good separation for azlocillin and sulbactam was obtained. Good linear relationships were observed in the concentration ranges of 0. 408- 20. 4 mg· L ^-1 ( r = 0. 999 0) and 1. 132 - 22.64 mg·L ^- 1 ( r = 0. 999 9 ), for azlocillin sodium and sulbactam sodium, respectively. The limit of detection of azolcillin sodi- um was 81.2 μg·L ^- 1 and that of sulbactam was 0. 566 mg· L ^- 1. The limits of quantification of azolcillin so- dium and sulbactam sodium were 0. 406 mg·L^- 1 and 1. 132 mg·L^- 1 ,respectively. Conclusions The method is simple, sensitive, and accurate, which can effectively determine the related substances of azlocillin sodium and sulbactam sodium for injection.
出处 《沈阳药科大学学报》 CAS CSCD 北大核心 2014年第10期783-788,共6页 Journal of Shenyang Pharmaceutical University
关键词 高效液相色谱法 阿洛西林钠 舒巴坦钠 有关物质 HPLC azlocillin sodium sulbactam sodium related substance
  • 相关文献

参考文献9

二级参考文献57

  • 1李家泰,齐慧敏,李耘,代表中国细菌耐药监测研究组.2002—2003年中国医院和社区获得性感染革兰阳性细菌耐药监测研究[J].中华检验医学杂志,2005,28(3):254-265. 被引量:225
  • 2黄永茂,张慧琳,穆国尧,卢毅,曾维华,朱淑媛.β-内酰胺类抗生素联合舒巴坦对产酶大肠杆菌的体外抗菌活性研究[J].中国抗生素杂志,1996,21(2):101-104. 被引量:13
  • 3颜青,肖永红,何绥平.必须重视β内酰胺类抗生素与其酶抑制剂复方制剂的科学开发[J].中国临床药学杂志,2007,16(4):259-261. 被引量:9
  • 4Schito GC, Pesce A, Debbia EA. 1-Stability in the presence of widespread beta-lactamases. A prerequisite for the antibacterial activity of beta-lactam drugs[J]. Drugs, 1994;47( Suppl. 3) :S1- S8.
  • 5Odenhoh-Tomqvist I, Lowdin E, Cars O. Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro[ J 1. Antimicrob Agents Chemother, 1991 ;35 : 1834-1839.
  • 6Fantin B, Pangon B, Potel G, et al. Activity of sulbactam in combination with ceftriaxone /n v/tro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like β-lactamase [ J ]. Antimicrob Agents Chemother, 1990 ;34:581-586.
  • 7Buijk SL, Gyssens IC, Mouton JW, et al. Pharmacokinetics of ceftazidime in serum and peritoneal exudate during continuous versus intermittent administration to patients with severe intra-abdomi- nal infections[ J]. J Antimicrob Chemother, 2002 ; 49 : 121-128.
  • 8Tumidge JD. The pharmacodyrlamics of beta-lactams[J]. Clin Infect Dis,1998; 27:10-22.
  • 9Pedeboscq S, Dubau B, Frappier S, et al. Comparison of 2 administration protocols ( continuous or discontinuous ) of a timedependent antibiotic[J]. Tazocin Pathol Biol, 2001 ; 49 : 540-547.
  • 10Rolinson GN, Geddes AM. The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA)[J]. Int J Antimicrob Agents, 2007, 29 (1) : 3-8.

共引文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部